in this issue
Chemical Week Magazine :: Newsbriefs
Genomatica Raises $41.5 Million, Withdraws IPO
8:32 AM MDT | August 3, 2012
Biobased technology company Genomatica (San Diego) says it has raised $41.5 million in a Series D financing round, which includes new investor and partner Versalis, and that it will withdraw its registration for a public offering. The funding will enable Genomatica to accelerate commercialization of its 1,4-butanediol (BDO) platform and expand its pipeline into other biochemicals, including butadiene, CEO and founder Christophe Schilling tells CW. Schilling says that the company determined private financing was the best option for Genomatica and its shareholders...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee